Ex-Allergan leader joins BioMarin board; Ex-FDA official Dr. Goodman joins GSK board; Dr. Reddy's relaunches generic Nexium in a new color;

> Former Allergan CEO David Pyott has joined BioMarin's board of directors. Report

> GlaxoSmithKline has named former FDA chief scientist Dr. Jesse Goodman to its board of directors. Release

> NHS has decided to return to its original recommendation that Merck's Ezetrol (Zetia) be used for treating primary hypercholesterolemia in some adults. Story

> Dr. Reddy's Laboratories has relaunched its generic version of AstraZeneca heartburn med Nexium after a U.S. court made it stop using the color purple. Story

Suggested Articles

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.